Skip to main content
Erschienen in: The Cerebellum 3/2010

01.09.2010

Cerebellar Glucose During Fasting and Acute Hyperglycemia in Nondiabetic Men and in Men with Type 1 Diabetes

verfasst von: Outi Heikkilä, Sari Mäkimattila, Marjut Timonen, Per-Henrik Groop, Sami Heikkinen, Nina Lundbom

Erschienen in: The Cerebellum | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

In diabetic patients, proton magnetic resonance spectroscopy (1H MRS) has revealed increased brain glucose concentration and metabolite alterations that indicate neuronal damage and glial cell activation. Cerebellum is known to be more resistant to hypoglycemia than cerebrum, but the effects of both chronic and acute hyperglycemia on the cerebellum are less well known. 1H MRS was used to quantify brain glucose and metabolite levels in the cerebellum, cerebral cortex, cerebral white matter, and the thalamus of diabetic and nondiabetic men after an overnight fast and during a hyperglycemic normoinsulinemic clamp with blood glucose 12 mmol/l above baseline. Fasting glucose levels were twice as high in the cerebellum than in the cerebrum. During acute hyperglycemia, the cerebellar glucose concentration increased by 3.0 mmol/l, which equals that in the cortex, but is 35% more than in the thalamus and 173% more than in the white matter. Acute hyperglycemia also increased the cerebellar tissue water content by 10%. There were no differences between diabetic and nondiabetic participants. Notably, the patients with complication free type 1 diabetes showed brain metabolite alterations in the cerebral cortex and the white matter but not in the cerebellum. Our study suggests that diabetes does not alter glucose content or uptake in the cerebellum. The increase in tissue water during acute hyperglycemia may serve to protect the cerebellum from the potentially deleterious effects of the excess glucose.
Literatur
1.
Zurück zum Zitat Wessels AM, Scheltens P, Barkhof F, Heine RJ (2008) Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. Eur J Pharmacol 585(1):88–96CrossRefPubMed Wessels AM, Scheltens P, Barkhof F, Heine RJ (2008) Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. Eur J Pharmacol 585(1):88–96CrossRefPubMed
2.
Zurück zum Zitat Miles WR, Rooth HF (1922) Psychologic tests applied in diabetic patients. Arch Intern Med 30:767–777 Miles WR, Rooth HF (1922) Psychologic tests applied in diabetic patients. Arch Intern Med 30:767–777
3.
Zurück zum Zitat Janghorbani M, Hu FB, Willett WC, Li TY, Manson JE, Logroscino G et al (2007) Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study. Diabetes Care 30(7):1730–1735CrossRefPubMed Janghorbani M, Hu FB, Willett WC, Li TY, Manson JE, Logroscino G et al (2007) Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study. Diabetes Care 30(7):1730–1735CrossRefPubMed
4.
Zurück zum Zitat van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ (2006) Brain imaging in patients with diabetes: a systematic review. Diabetes Care 29(11):2539–2548CrossRefPubMed van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ (2006) Brain imaging in patients with diabetes: a systematic review. Diabetes Care 29(11):2539–2548CrossRefPubMed
5.
Zurück zum Zitat Criego AB, Tkac I, Kumar A, Thomas W, Gruetter R, Seaquist ER (2005) Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness. J Neurosci Res 79(1–2):42–47CrossRefPubMed Criego AB, Tkac I, Kumar A, Thomas W, Gruetter R, Seaquist ER (2005) Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness. J Neurosci Res 79(1–2):42–47CrossRefPubMed
6.
Zurück zum Zitat Seaquist ER, Tkac I, Damberg G, Thomas W, Gruetter R (2005) Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy. Metabolism 54(8):1008–1013CrossRefPubMed Seaquist ER, Tkac I, Damberg G, Thomas W, Gruetter R (2005) Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy. Metabolism 54(8):1008–1013CrossRefPubMed
7.
Zurück zum Zitat Mäkimattila S, Malmberg-Ceder K, Häkkinen AM, Vuori K, Salonen O, Summanen P et al (2004) Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. J Cereb Blood Flow Metab 24(12):1393–1399CrossRefPubMed Mäkimattila S, Malmberg-Ceder K, Häkkinen AM, Vuori K, Salonen O, Summanen P et al (2004) Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. J Cereb Blood Flow Metab 24(12):1393–1399CrossRefPubMed
8.
Zurück zum Zitat Heikkilä O, Lundbom N, Timonen M, Groop PH, Heikkinen S, Mäkimattila S (2009) Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain. Diabetologia 52(3):534–540CrossRefPubMed Heikkilä O, Lundbom N, Timonen M, Groop PH, Heikkinen S, Mäkimattila S (2009) Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain. Diabetologia 52(3):534–540CrossRefPubMed
9.
Zurück zum Zitat Kreis R, Ross BD (1992) Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 184(1):123–130PubMed Kreis R, Ross BD (1992) Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 184(1):123–130PubMed
10.
Zurück zum Zitat Selvarajah D, Wilkinson ID, Emery CJ, Shaw PJ, Griffiths PD, Gandhi R et al (2008) Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus. Diabetologia 51(11):2088–2092CrossRefPubMed Selvarajah D, Wilkinson ID, Emery CJ, Shaw PJ, Griffiths PD, Gandhi R et al (2008) Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus. Diabetologia 51(11):2088–2092CrossRefPubMed
11.
Zurück zum Zitat Catani M, Mecocci P, Tarducci R, Howard R, Pelliccioli GP, Mariani E et al (2002) Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease. J Am Geriatr Soc 50(10):1707–1710CrossRefPubMed Catani M, Mecocci P, Tarducci R, Howard R, Pelliccioli GP, Mariani E et al (2002) Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease. J Am Geriatr Soc 50(10):1707–1710CrossRefPubMed
12.
Zurück zum Zitat Sinha S, Misra A, Kumar V, Jagannathan NR, Bal CS, Pandey RM et al (2004) Proton magnetic resonance spectroscopy and single photon emission computed tomography study of the brain in asymptomatic young hyperlipidaemic Asian Indians in North India show early abnormalities. Clin Endocrinol (Oxf) 61(2):182–189CrossRef Sinha S, Misra A, Kumar V, Jagannathan NR, Bal CS, Pandey RM et al (2004) Proton magnetic resonance spectroscopy and single photon emission computed tomography study of the brain in asymptomatic young hyperlipidaemic Asian Indians in North India show early abnormalities. Clin Endocrinol (Oxf) 61(2):182–189CrossRef
13.
Zurück zum Zitat Kario K, Ishikawa J, Hoshide S, Matsui Y, Morinari M, Eguchi K et al (2005) Diabetic brain damage in hypertension: role of renin-angiotensin system. Hypertension 45(5):887–893CrossRefPubMed Kario K, Ishikawa J, Hoshide S, Matsui Y, Morinari M, Eguchi K et al (2005) Diabetic brain damage in hypertension: role of renin-angiotensin system. Hypertension 45(5):887–893CrossRefPubMed
14.
Zurück zum Zitat Sahin I, Alkan A, Keskin L, Cikim A, Karakas HM, Firat AK et al (2008) Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diabetes Complicat 22(4):254–260CrossRefPubMed Sahin I, Alkan A, Keskin L, Cikim A, Karakas HM, Firat AK et al (2008) Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diabetes Complicat 22(4):254–260CrossRefPubMed
15.
Zurück zum Zitat Heikkilä O, Lundbom N, Timonen M, Groop PH, Heikkinen S, Mäkimattila S (2008) Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism. Metab Brain Dis 23(3):315–324CrossRefPubMed Heikkilä O, Lundbom N, Timonen M, Groop PH, Heikkinen S, Mäkimattila S (2008) Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism. Metab Brain Dis 23(3):315–324CrossRefPubMed
16.
Zurück zum Zitat Edlow JA, Newman-Toker DE, Savitz SI (2008) Diagnosis and initial management of cerebellar infarction. Lancet Neurol 7(10):951–964CrossRefPubMed Edlow JA, Newman-Toker DE, Savitz SI (2008) Diagnosis and initial management of cerebellar infarction. Lancet Neurol 7(10):951–964CrossRefPubMed
17.
Zurück zum Zitat Wessels AM, Simsek S, Remijnse PL, Veltman DJ, Biessels GJ, Barkhof F et al (2006) Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 49(10):2474–2480CrossRefPubMed Wessels AM, Simsek S, Remijnse PL, Veltman DJ, Biessels GJ, Barkhof F et al (2006) Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 49(10):2474–2480CrossRefPubMed
18.
Zurück zum Zitat Reske-Nielsen E, Lundbaek K, Rafeisen QJ (1965) Pathological changes in the cerebral and peripheral nervous system of young long-term diabetics. I. Diabetic encephalopathy. Diabetologia 1:233–241CrossRef Reske-Nielsen E, Lundbaek K, Rafeisen QJ (1965) Pathological changes in the cerebral and peripheral nervous system of young long-term diabetics. I. Diabetic encephalopathy. Diabetologia 1:233–241CrossRef
19.
Zurück zum Zitat Agardh CD, Siesjö BK (1981) Hypoglycemic brain injury: phospholipids, free fatty acids, and cyclic nucleotides in the cerebellum of the rat after 30 and 60 min of severe insulin-induced hypoglycemia. J Cereb Blood Flow Metab 1(3):267–275PubMed Agardh CD, Siesjö BK (1981) Hypoglycemic brain injury: phospholipids, free fatty acids, and cyclic nucleotides in the cerebellum of the rat after 30 and 60 min of severe insulin-induced hypoglycemia. J Cereb Blood Flow Metab 1(3):267–275PubMed
20.
Zurück zum Zitat Herzog RI, Chan O, Yu S, Dziura J, McNay EC, Sherwin RS (2008) Effect of acute and recurrent hypoglycemia on changes in brain glycogen concentration. Endocrinology 149(4):1499–1504CrossRefPubMed Herzog RI, Chan O, Yu S, Dziura J, McNay EC, Sherwin RS (2008) Effect of acute and recurrent hypoglycemia on changes in brain glycogen concentration. Endocrinology 149(4):1499–1504CrossRefPubMed
21.
Zurück zum Zitat LaManna JC, Harik SI (1985) Regional comparisons of brain glucose influx. Brain Res 326(2):299–305CrossRefPubMed LaManna JC, Harik SI (1985) Regional comparisons of brain glucose influx. Brain Res 326(2):299–305CrossRefPubMed
22.
Zurück zum Zitat Cranston I, Marsden P, Matyka K, Evans M, Lomas J, Sonksen P et al (1998) Regional differences in cerebral blood flow and glucose utilization in diabetic man: the effect of insulin. J Cereb Blood Flow Metab 18(2):130–140CrossRefPubMed Cranston I, Marsden P, Matyka K, Evans M, Lomas J, Sonksen P et al (1998) Regional differences in cerebral blood flow and glucose utilization in diabetic man: the effect of insulin. J Cereb Blood Flow Metab 18(2):130–140CrossRefPubMed
23.
Zurück zum Zitat Funari VA, Crandall JE, Tolan DR (2007) Fructose metabolism in the cerebellum. Cerebellum 6(2):130–140CrossRefPubMed Funari VA, Crandall JE, Tolan DR (2007) Fructose metabolism in the cerebellum. Cerebellum 6(2):130–140CrossRefPubMed
24.
Zurück zum Zitat Bingham EM, Dunn JT, Smith D, Sutcliffe-Goulden J, Reed LJ, Marsden PK et al (2005) Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study. Diabetologia 48(10):2080–2089CrossRefPubMed Bingham EM, Dunn JT, Smith D, Sutcliffe-Goulden J, Reed LJ, Marsden PK et al (2005) Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study. Diabetologia 48(10):2080–2089CrossRefPubMed
25.
Zurück zum Zitat Davis TM, Bruce DG, Davis WA (2005) Predictors of first stroke in type 1 diabetes: the Fremantle Diabetes Study. Diabet Med 22(5):551–553CrossRefPubMed Davis TM, Bruce DG, Davis WA (2005) Predictors of first stroke in type 1 diabetes: the Fremantle Diabetes Study. Diabet Med 22(5):551–553CrossRefPubMed
26.
Zurück zum Zitat McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M (1976) Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41(4):565–573PubMed McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M (1976) Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41(4):565–573PubMed
27.
Zurück zum Zitat Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 508:333–348CrossRefPubMed Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 508:333–348CrossRefPubMed
28.
Zurück zum Zitat Haase A, Frahm J, Hanicke W, Matthaei D (1985) 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 30(4):341–344CrossRefPubMed Haase A, Frahm J, Hanicke W, Matthaei D (1985) 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 30(4):341–344CrossRefPubMed
29.
Zurück zum Zitat Urenjak J, Williams SR, Gadian DG, Noble M (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59(1):55–61CrossRefPubMed Urenjak J, Williams SR, Gadian DG, Noble M (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59(1):55–61CrossRefPubMed
30.
Zurück zum Zitat Kado H, Kimura H, Murata T, Itoh H, Shimosegawa E (2004) Carbon monoxide poisoning: two cases of assessment by magnetization transfer ratios and 1H-MRS for brain damage. Radiat Med 22(3):190–194PubMed Kado H, Kimura H, Murata T, Itoh H, Shimosegawa E (2004) Carbon monoxide poisoning: two cases of assessment by magnetization transfer ratios and 1H-MRS for brain damage. Radiat Med 22(3):190–194PubMed
31.
Zurück zum Zitat Tofts PS, Waldman AD (2003) Spectroscopy: 1H metabolite concentrations. In: Tofts PS (ed) Quantitative MRI of the brain: measuring changes caused by disease. Wiley, New York, pp 299–340 Tofts PS, Waldman AD (2003) Spectroscopy: 1H metabolite concentrations. In: Tofts PS (ed) Quantitative MRI of the brain: measuring changes caused by disease. Wiley, New York, pp 299–340
32.
Zurück zum Zitat Schulman M (1994) Organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med 331(26):1776–1777PubMed Schulman M (1994) Organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med 331(26):1776–1777PubMed
33.
Zurück zum Zitat Lee JH, Arcinue E, Ross BD (1994) Brief report: organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med 331(7):439–442CrossRefPubMed Lee JH, Arcinue E, Ross BD (1994) Brief report: organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med 331(7):439–442CrossRefPubMed
34.
Zurück zum Zitat Long JB, Rigamonti DD, Dosaka K, Kraimer JM, Martinez-Arizala A (1992) Somatostatin causes vasoconstriction, reduces blood flow and increases vascular permeability in the rat central nervous system. J Pharmacol Exp Ther 260(3):1425–1432PubMed Long JB, Rigamonti DD, Dosaka K, Kraimer JM, Martinez-Arizala A (1992) Somatostatin causes vasoconstriction, reduces blood flow and increases vascular permeability in the rat central nervous system. J Pharmacol Exp Ther 260(3):1425–1432PubMed
35.
Zurück zum Zitat Smith JC, Lane H, Davies N, Evans LM, Cockcroft J, Scanlon MF et al (2003) The effects of depot long-acting somatostatin analog on central aortic pressure and arterial stiffness in acromegaly. J Clin Endocrinol Metab 88(6):2556–2561CrossRefPubMed Smith JC, Lane H, Davies N, Evans LM, Cockcroft J, Scanlon MF et al (2003) The effects of depot long-acting somatostatin analog on central aortic pressure and arterial stiffness in acromegaly. J Clin Endocrinol Metab 88(6):2556–2561CrossRefPubMed
36.
Zurück zum Zitat Reubi JC, Maurer R (1985) Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary. Neuroscience 15(4):1183–1193CrossRefPubMed Reubi JC, Maurer R (1985) Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary. Neuroscience 15(4):1183–1193CrossRefPubMed
37.
Zurück zum Zitat Uhl GR, Tran V, Snyder SH, Martin JB (1985) Somatostatin receptors: distribution in rat central nervous system and human frontal cortex. J Comp Neurol 240(3):288–304CrossRefPubMed Uhl GR, Tran V, Snyder SH, Martin JB (1985) Somatostatin receptors: distribution in rat central nervous system and human frontal cortex. J Comp Neurol 240(3):288–304CrossRefPubMed
38.
Zurück zum Zitat Martin JL, Chesselet MF, Raynor K, Gonzales C, Reisine T (1991) Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience 41(2–3):581–593CrossRefPubMed Martin JL, Chesselet MF, Raynor K, Gonzales C, Reisine T (1991) Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience 41(2–3):581–593CrossRefPubMed
39.
Zurück zum Zitat Ross B, Bluml S (2001) Magnetic resonance spectroscopy of the human brain. Anat Rec 265(2):54–84CrossRefPubMed Ross B, Bluml S (2001) Magnetic resonance spectroscopy of the human brain. Anat Rec 265(2):54–84CrossRefPubMed
40.
Zurück zum Zitat Soher BJ, Hurd RE, Sailasuta N, Barker PB (1996) Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn Reson Med 36(3):335–339CrossRefPubMed Soher BJ, Hurd RE, Sailasuta N, Barker PB (1996) Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn Reson Med 36(3):335–339CrossRefPubMed
41.
Zurück zum Zitat Kreis R, Arcinue E, Ernst T, Shonk TK, Flores R, Ross BD (1996) Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy. J Clin Invest 97(5):1142–1154CrossRefPubMed Kreis R, Arcinue E, Ernst T, Shonk TK, Flores R, Ross BD (1996) Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy. J Clin Invest 97(5):1142–1154CrossRefPubMed
42.
Zurück zum Zitat Ratcheson RA, Blank AC, Ferrendelli JA (1981) Regionally selective metabolic effects of hypoglycemia in brain. J Neurochem 36(6):1952–1958CrossRefPubMed Ratcheson RA, Blank AC, Ferrendelli JA (1981) Regionally selective metabolic effects of hypoglycemia in brain. J Neurochem 36(6):1952–1958CrossRefPubMed
43.
Zurück zum Zitat Bingham EM, Hopkins D, Smith D, Pernet A, Hallett W, Reed L et al (2002) The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 51(12):3384–3390CrossRefPubMed Bingham EM, Hopkins D, Smith D, Pernet A, Hallett W, Reed L et al (2002) The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 51(12):3384–3390CrossRefPubMed
44.
Zurück zum Zitat Hopkins DF, Williams G (1997) Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity. Diabet Med 14(12):1044–1050CrossRefPubMed Hopkins DF, Williams G (1997) Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity. Diabet Med 14(12):1044–1050CrossRefPubMed
45.
Zurück zum Zitat Wozniak M, Rydzewski B, Baker SP, Raizada MK (1993) The cellular and physiological actions of insulin in the central nervous system. Neurochem Int 22(1):1–10CrossRefPubMed Wozniak M, Rydzewski B, Baker SP, Raizada MK (1993) The cellular and physiological actions of insulin in the central nervous system. Neurochem Int 22(1):1–10CrossRefPubMed
46.
Zurück zum Zitat DiMattio J, Hochwald GM, Malhan C, Wald A (1975) Effects of changes in serum osmolarity on bulk flow of fluid into cerebral ventricles and on brain water content. Pflugers Arch 359(3):253–264CrossRefPubMed DiMattio J, Hochwald GM, Malhan C, Wald A (1975) Effects of changes in serum osmolarity on bulk flow of fluid into cerebral ventricles and on brain water content. Pflugers Arch 359(3):253–264CrossRefPubMed
Metadaten
Titel
Cerebellar Glucose During Fasting and Acute Hyperglycemia in Nondiabetic Men and in Men with Type 1 Diabetes
verfasst von
Outi Heikkilä
Sari Mäkimattila
Marjut Timonen
Per-Henrik Groop
Sami Heikkinen
Nina Lundbom
Publikationsdatum
01.09.2010
Verlag
Springer-Verlag
Erschienen in
The Cerebellum / Ausgabe 3/2010
Print ISSN: 1473-4222
Elektronische ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-010-0166-9

Weitere Artikel der Ausgabe 3/2010

The Cerebellum 3/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.